19
Views
23
CrossRef citations to date
0
Altmetric
CASE REPORT

Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia

, , , , &
Pages 429-435 | Received 02 Nov 2006, Accepted 28 May 2007, Published online: 02 Jan 2014

References

  • Choy EHS, Panayi GS. Mechanisms of disease: cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001;344:907–16.
  • Harris ED Jr. Rheumatoid arthritis: pathophysiology and implica-tions for therapy. N Engl J Med 1990;322(18):1277–89.
  • Katsikis PD, Chu C-Q, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179: 1517–27.
  • van Roon JAG, van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degrada-tion in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39: 829–35.
  • Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, et al. Interleukin-10 inhibition of the progression of estab-lished collagen-induced arthritis. Arthritis Rheum 1996;39(3): 495–503.
  • Persson S, Mikulowska A, Narula S, O'Garra A, Holmdahl R. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats. Scand J Immunol 1996;44(4607–14.
  • Tanaka Y, Otsuka T, Hotokebuchi T, Miyahara H, Nakashima H, Kuga S, et al. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res 1996;45(6):283–8.
  • Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP. Production of proinflammatory cytokines and cyto- kines involved in the TH1/TH2 balance is modulated by pentoxi-fylline. J Cardiovasc Pharmacol 1995;25 Suppl 2:S80–4.
  • Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleu-kin-10 gene promoter. Eur J Immunogenet 1997;24(41–8.
  • Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL-10 gene and further characterization of the 5' flanking sequence. Immunogenetics 1997;46(2):120–8.
  • Kube D, Platzer C, Von Knethen A, Straub H, Bohlen H, Hafner M, et al. Isolation of the human interleukin-10 promoter: charac-terization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 1995;7(41–7.
  • Koch W, Kastrati A, Böttiger C, Mehllli J, Von Beckerath N, Schiimig A. Interleukin-10 and tumor necrosis factor gene poly-morphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001;159(4137–44.
  • Kitawaki J, Obayashi H, Ohta M, Kado N, Ishihara H, Koshiba H, et al. Genetic contribution of the interleukin-10 promoter poly-morphism in endometriosis susceptibility. Am J Reprod Immunol 2002;47(412–8.
  • Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, et al. Interleukin-10 and interleukin-6 gene polymor-phisms as risk factors for Alzheimer's disease. Neurobiol Aging 2004;25(8):1009–15.
  • Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 pro-moter polymorphisms in southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1998;41(6):1090–5.
  • Yu L, Yang M-S, Zhao J, Shi Y-Y, Zhao X-Z, Yang J-D, et al. An association between polymorphisms of the interleukin-10 gene promoter and schizophrenia in the Chinese population. Schizophr Res 2004;71(4179–83.
  • Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthri-tis Rheum 1999;42(6):1101–8.
  • Coakley G, Mok CC, Hajeer AH, 011ier WER, Turner D, Sinnott PJ, et al. Interleukin-10 promoter polymorphisms in rheumatoid arthritis and Felty's syndrome. Br J Ftheumatol 1998;37(9): 988–91.
  • Huizinga TW, Keijsers V, Yanni G, Hall M, Ramage W, Lanchbury J, et al. Are differences in interleukin-10 production associated with joint damage? Ftheumatology 2000;39(11): 1180–8.
  • Cantagrel A, Navaux F, Loubet-Lescoulie P, Nourhashemi F, Enault G, Abbal M, et al. Interleukin-1, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999;42(6):1093–100.
  • Kaluza W, Leirisalo-Repo M, Märker-Hermann E, Westman P, Reuss E, Hug R, et al. IL-10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum 2001;44(5): 1209–14.
  • Hajeer AH, Lazarus M, Turner D, Mageed RA, Vencovsky J, Sinnott P, et al. IL-10 gene promoter polymorphisms in rheuma-toid arthritis. Scand J Ftheumatol 1998;27(2):142–5.
  • Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin-10 secretion in relation to human I L-10 locus haplotypes. Proc Natl Acad Sci USA 1998;95(16): 9465–70.
  • Keijsers V, Verweij CL, Westendorp RGJ, Breedveld FC, Huizinga TWJ. IL-10 polymorphisms in relation to production and rheumatoid arthritis. Arthritis Rheum 1997;40 Suppl 9:S179.
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthri-tis Rheum 1988;31(3):315–24.
  • Padyukov L, Hahn-Zoric M, Lau YL, Hanson LA. Different allelic frequencies of several cytokine genes in Hong Kong Chinese and Swedish Caucasians. Genes Immun 2001;2(5):280–3.
  • Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000;50:133–9.
  • Padyukov L, Hytönen A-M, Smolnikova M, Hahn-Zoric M, Nilsson N, Hanson L-A, et al. Polymorphism in promoter region of IL-10 gene is associated with rheumatoid arthritis in women. 31. J Rheumatol 2004;31(3):422–5.
  • Gröndal G, Kristjansdottir H, Gunnlaugsdottir B, Arnason A, 32. Lundberg I, Klareskog L, et al. Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase fami- lies. Arthritis Rheum 1999;42(8):1649–54.33.
  • Westendorp RG, Langermans JA, Huizinga TW, Verweij CL, Sturk A. Genetic influence on cytokine production in meningococ-cal disease. Lancet 1997;349(9069):1912–13.
  • Asadullah K, Sterry W, Volk HD. Interleukin-10 therapy: review of a new approach. Pharmacol Rev 2003;55(2):241–69.
  • Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999;1(2):151–5.
  • Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166(6):3915–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.